ETS1–EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling
Weifeng Ye, Sishun Gan, Qiang Xu, Xiaoyang Shu, Panpan Dong, Lin Li, Chao Tang · 2026
Read ETS1–EGR2 facilitates renal cell carcinoma progression by activating NOTCH signalling by Weifeng Ye, Sishun Gan, Qiang Xu, Xiaoyang Shu, Panpan Dong, Lin Li, Chao Tang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13478845.txt.
Description
Ye and colleagues in China traced in 2026 a gene chain that speeds clear cell kidney cancer, the most common and most deadly type of kidney tumor. Their hunt began with screens of tumor samples and gene banks. One switch gene, ETS1, stood far higher in tumor tissue than in sound kidney. The team then raised or cut the switch in cancer cells and in tumors grown in mice.
More ETS1 made cells grow, move, and spread with more force, and tumors in mice grew faster. The switch works by grabbing a brake gene, EGR2, and marking its protein for shredding. With the brake gone, a growth path called NOTCH runs free, since EGR2 once held it down through a partner switch. The authors name the three link chain a drug target: cut any link, and the growth path may stall.
Catalog record
| CREATOR | Weifeng Ye, Sishun Gan, Qiang Xu, Xiaoyang Shu, Panpan Dong, Lin Li, Chao Tang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |